Other
Hyaluronate
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Hyaluronate is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
9
clinical trials
Unknown status4 · 44%
Completed4 · 44%
Not yet recruiting1 · 11%
Clinical Trials
Trial Activity
9 trials
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
Completed·—·Phase 4·NCT01614847·8 enrolled
Impact of 0.1% and 0.2% Sodium Hyaluronate on Postoperative Discomfort Following Phacoemulsification Surgery
Completed·—·N/A·NCT03705949·180 enrolled
0.3% Sodium Hyaluronate Eye Drop to Prevent Recurrent Corneal Epithelium Exfoliation
Unknown status·—·Phase 3·NCT03000556·60 enrolled
Chitosan-Hyaluronate Gel Mixture Vs Hyaluronic for Internal Derangement
Unknown status·—·Phase 4·NCT06426199·20 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)